Evaluation of Free Air Portable Air Powered Respirator
NCT02487147 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 58
Last updated 2022-03-04
Summary
This study will compare the efficacy of the Free Air Portable Air Powered Respirator (PAPR) system versus a N95 mask in preventing nasal detection of influenza following an exposure. The investigators hypothesize the use of the Free Air PAPR system will be superior to a N95 respirator at interrupting the exposure of the study participants to aerosolized influenza virus particles.
Conditions
Interventions
- OTHER
-
Free Air Portable Air Powered Respirator
The Free Air PAPR is a portable air powered respirator that you will wear like a backpack with a mask and tubing attached.
- OTHER
-
N95 Respirator
The N95 respirator is a mask that is standardly used clinically at Wake Forest Baptist Health.
Sponsors & Collaborators
-
Free Air
collaborator UNKNOWN -
Wake Forest University Health Sciences
lead OTHER
Principal Investigators
-
Werner Bischoff, MD, PhD · Wake Forest University Health Sciences
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 49 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-11-14
- Primary Completion
- 2016-12-12
- Completion
- 2016-12-12
Countries
- United States
Study Locations
More Related Trials
-
Safety, Tolerability, Efficacy and Immunogenicity of an Influenza A Vaccine (FP-01.1) in Healthy Volunteers Following Virus Challenge
NCT02071329 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Dose, Safety, and Pathogenicity of a New Influenza A H3N2 Challenge Strain
NCT06613737 ·Status: COMPLETED ·Phase: NA
-
Pre-Approval Access to Pimodivir for the Treatment of Patients With H7N9 Influenza A Infection
NCT03834376 ·Status: NO_LONGER_AVAILABLE
-
Immunogenicity and Safety Study of Inactivated Subunit H5N1 Influenza Vaccine in Prior Recipients of Live Attenuated H2N2, H6N1 and H9N2 Influenza Vaccines and in H5N1 and Live Attenuated Vaccine Naïve Individuals
NCT03816878 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age
NCT06602024 ·Status: COMPLETED ·Phase: PHASE3
-
A Study To Learn About The Study Vaccine (Called Self-Amplifying Ribonucleic Acid (RNA)) For The Prevention of Influenza
NCT05227001 ·Status: COMPLETED ·Phase: PHASE1
-
Influenza Challenge Study to Determine the Optimal Infection Dose and Safety of a Recombinant H3N2 (A/Texas/71/2017 (H3N2, Clade 3C3a) Influenza Strain
NCT04978454 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity Study of H3N2 M2SR Monovalent Influenza Vaccine in Healthy Volunteers
NCT02822105 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of an Investigational Flu Seasonal/SARS-CoV-2 Combination Vaccine in Adults
NCT06680375 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of mRNA-1018 Pandemic Influenza Candidate Vaccines in Healthy Adults
NCT05972174 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
NCT00800605 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 3 Study of a H5N1 Vaccine in Adults, Elderly and Specified Risk Groups
NCT00711295 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of Inhaled PUR003 on a Controlled Influenza Virus Challenge in Healthy Adult Subjects
NCT00947687 ·Status: COMPLETED ·Phase: PHASE1
-
Vaccine Pandemic Preparedness Through Airway Immunology Characterization
NCT05921448 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Infectivity, Replication & Immunogenicity of Live nH1N1 Vaccine
NCT01023776 ·Status: COMPLETED ·Phase: PHASE4
-
Influenza Vaccine in Lung Transplant Patients - Persistence of Antibodies
NCT04531787 ·Status: COMPLETED
-
A Study of Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Children Aged 6 Months to 9 Years
NCT00952419 ·Status: COMPLETED ·Phase: PHASE2
-
DMID 21-0041; Influenza CVD 59000
NCT05666245 ·Status: COMPLETED ·Phase: NA
-
A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine
NCT02251288 ·Status: COMPLETED ·Phase: PHASE1
-
Administration of the Nasal Influenza Vaccine to Children in Daycare or at a Healthcare Facility
NCT07310472 ·Status: RECRUITING ·Phase: NA
-
Safety and Immunogenicity of Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure
NCT01045564 ·Status: WITHDRAWN ·Phase: PHASE2
-
Evaluation of Pandemic Vaccination Campaign
NCT01024725 ·Status: COMPLETED
-
Comparing the Efficacy and Safety of High-Titer Versus Low-Titer Anti-Influenza Immune Plasma for the Treatment of Severe Influenza A
NCT02572817 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating the Safety and Immunogenicity of a H7N9 Vaccine for the Prevention of Influenza H7N9 Disease in Adults 50 to 70 Years Old
NCT02274545 ·Status: COMPLETED ·Phase: PHASE1
-
A Study for Evaluation of Immunogenicity and Reactogenicity of FluarixTM / Influsplit SSW® 2009/2010 in Adults
NCT00920374 ·Status: COMPLETED ·Phase: PHASE3